Here are six takeaways:
1. Dr. Thomas will succeed Wolf-Dietrich Hübner, MD, who is retiring.
2. A seasoned executive, Dr. Thomas has served as a medical practitioner for several organizations.
3. He has been actively involved in clinical research and product development.
4. In his new role, Dr. Thomas will head curasan’s medical affairs, clinical research, regulatory affairs and quality systems departments.
5. Dr. Thomas will serve on the company’s senior management team.
6. curasan develops, manufactures and makes bone and tissue regeneration products and biomaterials.
More articles on devices:
Zimmer Biomet jumps into value-based care with Signature Solutions: 5 things to know
5 key trends to watch for Mazor in the growing spinal robotics field
Open Payments data may need more nuance, S.C. physicians say — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
